title: Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion.
authors.forename: Laura
authors.initials: L
authors.lastname: Cannella
authors.forename: Roberto
authors.initials: R
authors.lastname: Latagliata
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Ida
authors.initials: I
authors.lastname: Carmosino
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Loglisci
authors.forename: Paola
authors.initials: P
authors.lastname: Volpicelli
authors.forename: Antonietta
authors.initials: A
authors.lastname: Ferretti
authors.forename: Michelina
authors.initials: M
authors.lastname: Santopietro
authors.forename: Federico
authors.initials: F
authors.lastname: Vozella
authors.forename: Corrado
authors.initials: C
authors.lastname: Girmenia
authors.forename: Mariella
authors.initials: M
authors.lastname: Cuzzola
authors.forename: Esther Natalie
authors.initials: EN
authors.lastname: Oliva
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000368:Aged; D000740:Anemia / Q000139:chemically induced*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide